Ondrej Slaby

10PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 26, 2026
Young Age Is Associated with Improved Survival After Resection of Non-Metastatic Pancreatic Ductal Adenocarcinoma.

|Aug 04, 2025
Real-World Data From a Molecular Tumor Board-Assisted Cancer Care From a Single Center in The Czech Republic: Is Precision Oncology an Accessible Option, or a Privilege for a Minority of Patients?

Michal Eid, Markéta Bednaříková, Jakub Vlažný

|Apr 21, 2025
Neoadjuvant treatment of locally advanced rectal cancer - a consensus procedure Comprehensive Cancer Center Brno.

P Pospíšil, E Dvořáková, P Šlampa

|Feb 10, 2025
Minimal invasive surgery of pancreatic cancer at the Department of Surgery of Masaryk university hospital Brno, Czech Republic.

J Hlavsa, T Pavlík, D Marek

|Dec 07, 2024
The role of neoadjuvant treatment in localized pancreatic cancer.

R Němeček, M Eid

|May 22, 2024
Incidental germline findings during comprehensive genomic profiling of pancreatic and colorectal cancer: single-centre, molecular tumour board experience.

Michal Eid, Jakub Trizuljak, Renata Taslerova

Pageof 2

Frequent Collaborators

3 joint publications

Radim Němeček

3 joint publications

Zdeněk Kala

3 joint publications

Jan Trna

3 joint publications

Lumír Kunovský